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Background: Prenatal androgen exposure has been hypothesized to be linked to autism spectrum disorder (ASD).
While previous studies have found a link between testosterone levels in amniotic fluid and autistic-like traits, a similar
relationship has not been found for testosterone in umbilical cord blood. However, it may be the net biological activity
of multiple androgens and estrogens that influences postnatal effects of prenatal sex steroids. Accordingly, composite
levels of androgens (A) and estrogens (E) were investigated, along with their ratio, in relation to autistic-like traits in
young adulthood.
Methods: Sex steroid data in umbilical cord blood were available from 860 individuals at delivery. Samples were
analyzed for androgens (testosterone, androstenedione, and dehydroepiandrosterone) and estrogens (estrone,
estradiol, estriol, and estetrol). Levels of bioavailable testosterone, estradiol, and estrone were measured and used
to calculate A and E composites and the A to E ratio. Participants were approached in early adulthood to complete the
autism-spectrum quotient (AQ) as a self-report measure of autistic-like traits, with 183 males (M = 20.10 years,
SD = 0.65 years) and 189 females (M =19.92 years, SD = 0.68 years) providing data.
Results: Males exhibited significantly higher androgen composites and A to E composite ratios than females.
Males also scored significantly higher on the details/patterns subscale of the AQ. Subsequent categorical and
continuous analyses, which accounted for covariates, revealed no substantial relationships between the A/E
composites or the A to E ratio and the AQ total or subscale scores.
Conclusions: The current study found no link between the A/E composites or the A to E ratio in cord blood
and autistic-like traits in the population as measured by the AQ. These outcomes do not exclude the possibility
that these sex steroid variables may predict other neurodevelopmental traits in early development.
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QuotientBackground
Autism spectrum disorder (ASD) varies significantly in
presentation among those affected [1]. It is therefore un-
surprising that the etiology of ASD is thought to be
similarly heterogeneous and multifaceted in nature. At
present, much remains unknown about the factors that* Correspondence: esha.jamnadass@research.uwa.edu.au
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creativecommons.org/publicdomain/zero/1.0/may underlie the disorder [2]. Research involving the
identification of early markers is integral to improving
our understanding of the mechanisms underlying the
disorder and is likely to significantly impact intervention
and outcomes for affected individuals [3].
Males are approximately four times more likely than
females to be diagnosed with ASD [4, 5]. The extreme
male brain theory [6] posits that this may be because
characteristics of ASD are on the extreme end of a
spectrum of male-typical characteristics. A growing litera-
ture has investigated the factors that may trigger brainss article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Jamnadass et al. Journal of Neurodevelopmental Disorders  (2015) 7:17 Page 2 of 12masculinization, in particular, by examining possible
prenatal biological influences affecting brain develop-
ment and later behavior. The organizational hypothesis
proposes that prenatal sex steroid exposure affects fetal
brain structure and function and consequently influ-
ences postnatal behavior [2]. It is proposed that greater
exposure to testosterone (one of the most biologically
active androgens) during a sensitive developmental period
(weeks 8–24 of gestation) may have masculinizing effects
on the fetal brain [7] and hence may be a precursor to
autistic-like traits. Circulating testosterone measured in
blood samples has been found to be significantly higher in
male fetuses than in female fetuses in utero [8].
Prenatal exposure to androgens has been demonstrated
to affect a wide range of developmental factors [9]. There
is a plethora of research in animal studies that has re-
vealed the effects of androgens as a masculinizing agent in
both primate and non-primate species [10–13]. Testoster-
one has primarily been the focus of research due to its
biological potency (its ability to exert receptor-mediated
changes in cellular or physiological function); however,
there is also preliminary evidence that other androgens
such as androstenedione (A4) may have masculinizing ef-
fects [14]. Dehydroepiandrosterone (DHEA) has also been
suggested to be involved with weak masculinization [15].
In humans, evidence on the masculinizing role of andro-
gens has come in part from research on individuals with
congenital adrenal hyperplasia (CAH). CAH occurs as a
result of a genetic abnormality that triggers an overpro-
duction of androgens in utero. As a result, female fetuses
are exposed to elevated androgen levels that fall within or
above the male-typical range. These, and other studies,
support the idea that elevated levels of androgens can re-
sult in brain and hence behavioral masculinization [16],
though it has been argued that this research may not take
into account social and sample characteristics that might
influence these findings [17]. Often, the effects of testos-
terone on autistic-like traits have been investigated using
indirect methods, such as hand digit ratios. The 2D:4D ra-
tio refers to the ratio of the relative lengths of the second
and fourth digits. This ratio has been used for over a cen-
tury as an indirect measure of prenatal exposure to testos-
terone and estradiol, the primary biologically active sex
steroid in females [18]. There is some evidence of this
ratio being related to prenatal sex steroid levels in amni-
otic fluid [19]. It is posited to be related to adult endocrine
system regulation traits such as aggression and sexual
encounters [20]. Overall, indirect measures such as the
2D:4D ratio do not show consistent associations with
autistic-like traits [7, 21]. Furthermore, the validity of this
marker as a representation of sex steroid concentrations is
still debatable [22]. The digit ratio measure can be con-
sidered an insufficiently sensitive proxy for examining
prenatal hormonal effects [23].In contrast, other studies have attempted to examine
prenatal testosterone exposure via direct measurement
of sex steroids in amniotic fluid, collected by amniocen-
tesis during the second trimester. This procedure typic-
ally occurs during a proposed sensitive time period
when sex steroids are considered to have organizational
effects on brain development [24]. Amniotic fluid testos-
terone concentrations have been found to be signifi-
cantly greater in males compared to females [25].
With regard to ASD, a group of studies conducted by
Baron-Cohen and colleagues found that high levels of
fetal testosterone in amniotic fluid were related to
autistic-like traits in children aged 18 to 24 months for
boys [26], decreased eye contact in 1-year-old children
[27], increased restricted interests in 4-year-old boys
[28], reduced empathy in 6- to 8-year-old children for
boys [29], and greater autistic-like traits in children
aged 6 to 10 [30]. Furthermore, a more recent study in
a large pregnancy cohort found a latent steroidogenic
factor that included cortisol as well as all hormones in
the Δ4 pathway (progesterone, 17α-hydroxy-progesterone,
androstenedione, and testosterone) was significantly ele-
vated in the amniotic fluid of males who later received
diagnoses of ASD. However, testosterone alone was not
found to be related to a later diagnosis of ASD [31]. How-
ever, amniocentesis is often carried out in older women or
those with other risk factors and so the results may not be
representative of the normal population [32].
The literature suggests that there may be multiple
sensitive periods during which sex steroids affect brain
functioning and structure [33]. This position is further
supported by research in animal models, which has
found that the effects of sex steroids are not restricted
to the first two trimesters [33–35]. Recently, studies
from the Western Australian Pregnancy Cohort (the
‘Raine’ cohort) have measured sex steroid levels in um-
bilical cord blood at birth [36, 37]. Measuring sex steroids
in cord blood is useful because it can provide an indica-
tion of how sex steroids may play a role in brain develop-
ment in late gestation. Furthermore, this method may
enable more representative assessment of antenatal steroid
exposure on a population level [23]. The cord blood ana-
lysis also permits direct assessment of circulating fetal
steroid concentrations as opposed to amniotic fluid which
primarily reflects fetal urinary testosterone excretion [32].
The third trimester is a period where dramatic brain
growth occurs and is an important period for neuronal
maturation, gyrification, and rapid axonal growth [38].
Umbilical cord sex steroids are known to relate to a
range of informative childhood development markers,
such as language development [39, 40], internalizing
and externalizing behaviors [41], and spatial abilities
[42], and are therefore worth examining in relation to
autistic-like traits.
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cohort cord blood samples showed that high levels of
cord blood testosterone were associated with language
delay in boys but not girls [40, 43]. In contrast, another
study found no relationship between testosterone con-
centrations and autistic-like traits measured at age 19 or
20 years via the autism-spectrum quotient AQ [44].
Previous studies have focused in general on androgens
and testosterone in particular. However, there is evi-
dence to suggest that estrogens, in particular estradiol,
may promote masculinization, as has been demonstrated
in rodent models [2]. It has been proposed that estradiol
promotes cell survival, death, and proliferation in separ-
ate brain regions. It may facilitate new dendritic spine
synapses in some brain regions but suppress them in
others. The effects of estradiol may be mediated in part
via epigenetic changes to the DNA and chromatin in
processes that are region-specific but are still poorly
understood [34].
Though empirical evidence for the effects of estrogens
on human neural development is lacking, androgen and
estrogen exposure has been postulated to be responsible
for a variety of sexually dimorphic neurodevelopmental
and behavioral characteristics including reproductive
function [35] and immune function [45]. Sex steroids
interact with and may enhance or limit the effects of
each other [46, 47]. The nature of potential interactions
between androgens and estrogens remains to be investi-
gated. Previous studies have investigated the relative
amounts of androgens and estrogens in relation to the
2D:4D ratio. One study involved the ratio between tes-
tosterone and estradiol [19] while the other looked at
the ratio between androgen and estrogen composites
[48]. The relative amounts of androgens to estrogens
therefore may be worth examining.
The present research therefore sought to extend previ-
ous studies by expanding the number of sex steroids
assessed through deriving androgen and estrogen com-
posites using the novel method developed by Hollier
et al. [23]. Sex steroid composites and their ratio were
then used as possible predictors of autistic-like traits in
both the general population and a subset of individuals
with ASD. Sex steroids were measured in umbilical cord
blood collected at birth, and A and E composites and
their ratio were calculated. The androgen composite
weights the concentrations of testosterone, A4, and
DHEA according to their relative biological potencies
and binding affinities to sex-hormone binding globulin
(SHBG). The estrogen composite weights the concentra-
tions of estrone (E1), estradiol (E2), estriol (E3), and
estetrol (E4) in a similar manner. Based on the free hor-
mone hypothesis, bioavailable sex steroid concentrations
were calculated for testosterone, estradiol, and estrone.
While this method has been criticized on the basis ofmethodological inconsistency and unproved assumptions
[49], it remains the traditional method for examining
bioactive sex steroids and is widely accepted [50]. For
the present study, ASD diagnostic measures had been
collected in childhood and the AQ had been adminis-
tered in early adulthood.
It is hypothesized that, based on previous masculinization
studies, a high A composite (and possibly A to E ratio)
would be associated with increased autistic-like traits in the
whole sample and that those individuals with a clinical
diagnosis of ASD would have particularly high A and pos-
sibly high A to E ratios. Furthermore, it was expected that
these associations would occur for outcome variables that
demonstrate a sex difference.Methods
Participants
The Raine study is a longitudinal investigation of women
and their offspring recruited from the public antenatal
clinic at King Edward Memorial Hospital or surrounding
private clinics, between May 1989 and November 1991.
The sample consisted of 2900 women who had a specific
gestational age (between 16 and 20 weeks), English lan-
guage skills, an expectation to deliver at King Edward Me-
morial Hospital, and an intention to remain in Western
Australia to enable future follow-up of their child [51]. By
the end of the recruitment period, 2868 live births (96 %)
were available for follow-up. Informed consent was ob-
tained from all mothers and offspring who participated.
The Human Ethics Committee at King Edward Memorial
Hospital and/or Princess Margaret Hospital for Children
in Perth approved participant recruitment and all follow-
ups of the study families.Measures
Sex steroid measurement
Mixed arterial and venous umbilical cord blood was ob-
tained at the birth of 860 deliveries from the intensive
ultrasound arm of the cohort which consisted of 1415
singleton pregnancies in total. We confirmed absence of
detectable maternal contamination by Mendelian con-
cordance analysis of DNA from matched maternal and
cord blood in ten randomly selected sample sets from
the cohort using the Affymetrix genome-wide human
single nucleotide polymorphisms array 6.0. Immediately
after delivery, mixed umbilical arterial-venous (UA to
UV ratio) cord blood was collected and allowed to clot
and the resulting serum was frozen at −80 °C and stored
without thawing until the present study was performed.
Eight hundred and three cord blood samples (92.3 %)
representing 407 male and 396 female infants had suffi-
cient serum (after removal, aliquoting and archiving of
1 ml for future studies) for steroid analysis. In January
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for sex steroid content.
Liquid chromatography-tandem mass spectrometry
(LCMS/MS) was used to measure total testosterone
(TT), A4, and DHEA as described by Keelan et al. [37].
E1, E2, E3, and E4 were measured by LCMS after solvent
extraction, as described in detail by Hickey, Hart, and
Keelan [36].
SHBG was measured by ELISA using a commercial kit
(IBL International, Hamburg, Germany) according to the
manufacturer’s instructions. All samples were measured
in duplicate by a single operator using assay kits from
the same batch. The inter-assay imprecision was <4.5 %
(n = 25). Intra-assay variation was 5.2 % (n = 861). Sam-
ples with an initial replicate coefficient of variation (CV)
of >10 % were reanalyzed [37].
Calculation of bioavailable testosterone, estradiol, and
estrone
BioT (nmol/L), representing the fraction of total testos-
terone either free (unsequestered by SHBG) or bound to
serum albumin, was calculated using the following for-
mula [37]
BioT ¼ free testosterone½  þ albumin‐bound testosterone½ 
Free testosterone was calculated using the empirical
method and formula described by Sartorius and col-
leagues [52]. Albumin levels were adjusted using pub-
lished reference values to take into account the decrease
in serum albumin concentrations with gestational age
[53]. Bioavailable concentrations of E1 (BioE1) and of
E2(BioE2) were calculated using the method described
by Mazer [54] and adjusted accordingly as described in
detail by Hollier et al. [23].
Composite measures
The calculated composites take into account the bio-
logical potency, binding affinity, and unbound propor-
tion of the sex steroids. Each steroid is weighted
according to its biological potency and the following
formulas are used:
Androgen composite ¼ BioTþ 0:1 A4½ 
þ 0:01 DHEA½ 
Estogen composite ¼ BioE1 þ BioE1½  þ 0:1 E3½ 
þ 0:02 E4½ 
The formulas used to calculate the composites are ex-
plained in detail in Hollier et al. [23]. The A to E ratio
was calculated by dividing the androgen composite by
the estrogen composite.ASD diagnosis
Diagnoses were recorded at the 5-, 8-, 10-, 14-, and
17-year follow-ups by asking the parent if a diagnosis
of ASD had ever been made by health professionals.
Diagnoses were obtained based on the consensus of a
speech-language pathologist, psychologist, and pediatrician
as mandated in Western Australia.
Autism-spectrum quotient (AQ)
The AQ was completed by participants at age 19 or
20 years with the exception of adults with a known diag-
nosis of any intellectual disability or ASD (due to ethical
concerns). The AQ is a 50-item self-report questionnaire
designed to measure autistic-like traits in the general
population (Baron-Cohen et al. [55]). The items were
scored on a 1–4 scale that has been shown to retain
more information (see [56]) than the dichotomous scor-
ing described by Baron-Cohen et al. [55]. In contrast to
the subscale structure proposed by Baron-Cohen et al.
[55], factor analyses of the AQ have identified varying
factor structures [56–58]. In the current study, we di-
vided items into the three subscales identified in a pre-
vious study of Western Australian young adults [59]:
social skills (13 items), details/patterns (7 items), and
communication/mindreading (8 items). For the current
data set, internal reliability (α) for the scales was 0.63
for communication/mind-reading, 0.78 for details/pat-
terns, and 0.85 for social skills. Scores for the items within
each subscale were then summed to provide a quantitative
measure of that particular autistic-like trait, with higher
scores representing more autistic-like traits.
Sample characteristics
A number of additional variables were recorded at vari-
ous time points. Sociodemographic variables (maternal
age at conception, maternal education, family income)
were recorded at 18 weeks’ pregnancy, antenatal vari-
ables (maternal smoking and alcohol consumption dur-
ing pregnancy) at 34 weeks’ pregnancy, and obstetric
variables (gestational age, offspring gender, parity, Apgar
scores 5 min after delivery) at birth. Proportion of opti-
mal birth weight was also calculated based on the ratio
of the observed birth dimension to the optimal birth di-
mension for that individual neonate [60]. This provided
a measure of the appropriateness of fetal growth. Further
investigation of these variables was carried out to assess
the representativeness of the individuals whose cord
blood sex steroids and AQ data were available compared
to the broader cohort with sex steroid data.
Statistical analysis
As a preliminary check, a principal component analysis
with a direct oblimin rotation was conducted on the
seven sex steroid variables to determine if the androgens
Jamnadass et al. Journal of Neurodevelopmental Disorders  (2015) 7:17 Page 5 of 12and estrogens formed two separate factors. As expected,
the variables loaded on two components with the estro-
gens loading on the first component (range of loadings
0.76 to 0.88) and the androgens on the second (range
0.63 to 0.72), with cross loadings no higher than 0.46.
The literature suggests that prenatal testosterone expos-
ure may exert varying effects between sexes [43]. As a
result, all subsequent analyses were carried out after seg-
regating by sex.
Our hypothesis was that the A composite (and perhaps
the A to E ratio) contributes to between sex differences
in autistic-like characteristics. Therefore, independent
sample t tests were conducted in order to determine if
sex differences existed. This was followed by correlational
and hierarchical multiple linear regression analyses using
the sex steroid variables to predict AQ scores. For the
regression analyses, covariates that showed a correlation
with the outcome variable (score on relevant AQ scale) at
the level of p < .2 were included in the first block using the
enter method, while each predictor variable (A, E or A to
E ratio) was added in the second block.
The data were then investigated categorically to deter-
mine whether sex steroid exposure was associated with
high scores on the AQ and its subscales. High scores
were defined as scores in the upper decile of a particular
scale. Sex differences were examined via chi-square
analyses, and scales that demonstrated a significant sex
difference were examined in relation to sex steroid
composite values. For these scales, chi-square analyses
were conducted separately for each sex by forming
quartiles of androgen, estrogen, and A to E ratios and
cross-tabulating these with high scores on the particular
AQ scale. Any significant difference on any scale was
followed up with multivariate logistic regression, following
the same two-step procedure outlined for the multivariate
linear regression analyses. For all analyses, an alpha level
of 0.05 was adopted.
Additional analyses of androgen levels, estrogen levels,
and their ratios in individuals with an ASD diagnosis
were conducted. Z score conversions of these values en-
abled them to be compared to the wider sample.
Results
Sample characteristics
Sex steroid data were available for 860 children. Of
these, 705 (82 %) provided additional diagnostic data at
the 5-, 8-, 10-, 14-, or 17-year follow-ups. Of those who
had sex steroid and postnatal diagnostic data available,
183 of 364 (50.2 %) males and 189 of 341 (55.4 %) fe-
males also completed the AQ. Although age was signifi-
cantly different for males (M = 20.10, SD = 0.65) and
females (M = 19.92, SD = 0.68) who completed the AQ,
t(370) = 2.64, p = .01, this difference was small, Cohen’s
d = 0.27. A chi-squared analysis was used to comparethe characteristics of those who did and did not complete
the AQ within the sample of those who had available sex
steroid data. Table 1 presents the characteristics of the
two groups. The mothers of those who did not complete
the AQ were more likely to be younger, less likely to have
completed secondary school, smoke cigarettes and drink
alcohol while pregnant as well as earn an income less than
the government-defined poverty line of $AUD 24,000.
However, there was no difference between individuals
who did and did not complete the AQ in terms of gesta-
tional age at birth, proportion of optimal birth weight,
parity or Apgar scores 5 min after birth. There was no
significant difference between males who did or did not
complete the AQ in androgen, t(362) = 0.86, p = .39, es-
trogen, t(362) = 1.47, p = .14, or ratio, t(337.07) = 1.21,
p = .23, composite values. Females who did versus did
not complete the AQ did not differ significantly in an-
drogen, t(339) = 1.09, p = .28, or estrogen, t(339) = 0.81,
p = .42, composite values. However, females who com-
pleted the AQ (M = 0.0046, SD = 0.0025) had a signifi-
cantly lower A to E composites ratio than females who
did not complete the AQ (M = 0.0064, SD = 0.0099),
t(339) = 2.43, p < .05, Cohen’s d = 0.25.
Sex differences in sex steroid composite values and AQ
scores
Table 2 shows descriptive statistics for the sex steroid
(androgen composite, estrogen composite, and A to E
ratio) and AQ variables for males and females. Inde-
pendent sample t tests were used to examine any sex dif-
ferences after a logarithmic transformation was applied
to any variables for which |skewness| >1. The results of
these analyses are presented in Table 2. Analysis of the
sex steroid composites and ratio revealed that males had
significantly higher androgen levels compared to females
(p < .01) and a higher A to E ratio (p < .05); however,
there was no significant difference in estrogen levels
between sexes.
Analyses of the AQ scores revealed that males scored
significantly higher than females on the details/patterns
subscale (p < .01) and there was a trend towards signifi-
cantly higher scores for males on the total AQ score
(p = .05). No sex differences were found on the social
skills or the communication/mindreading subscales.
Sex steroid composite values and AQ scores
Spearman’s rank order correlations were conducted to
investigate relationships between the sex steroid variables
and AQ variables separately for males and females. All
correlations were non-significant as displayed in Table 3.
Analyses were also conducted according to the original
(dichotomous) AQ scoring and five-subscale structure,
but again no significant correlations were demonstrated
[see Additional file 1].
Table 1 Characteristics of those who did and did not complete the AQ
Categorical variables Completed AQ (n = 372) Did not complete AQ (n = 333) p value
Number n (%) Number n (%)
Maternal age at birth 364 321 <.01
<20 19 (5.2) 32 (10)
20–24 65 (17.9) 73 (22.7)
25–29 90 (24.7) 108 (33.6)
30–34 119 (32.7) 76 (23.7)
35+ 71 (19.5) 32 (10)
Maternal education at pregnancy 364 321 <.01
Completed secondary school 155 (42.6) 216 (67.3)
Did not complete secondary school 209 (56.2) 105 (32.7)
Family income below poverty line 362 319 <.01
Yes 115 (31.8) 149 (46.7)
No 247 (66.4) 170 (53.3)
Maternal smoking in pregnancy 364 321 <.05
None 291 (79.9) 224 (69.8)
1–10 cigarettes daily 42 (11.5) 56 (17.4)
11+ cigarettes daily 31 (8.5) 41 (12.8)
Maternal alcohol intake during pregnancy 364 321 <.05
None 199 (54.7) 213 (66.4)
Once a week or less 141 (38.7) 88 (27.4)
Several times a week or more 24 (6.6) 20 (6.2)
Gestational age 364 321 .87
<32 weeks 3 (0.8) 7 (2.2)
32 to 37 weeks 64 (17.6) 48 (15.0)
38 to 40 weeks 230 (63.2) 211 (65.7)
>40 weeks 67 (18.4) 55 (17.1)
Proportion of optimal birth weight 370 333 .39
<90 117 (31.6) 96 (28.8)
90 to 110 206 (55.7) 184 (55.3)
>110 47 (12.7) 53 (15.9)
Sex 372 333 .11
Male 183 (49.2) 181 (54.4)
Female 189 (50.8) 152 (45.6)
Apgar score 364 320 .94
Generally normal 351 (96.4) 309 (96.6)
Fairly low 13 (3.6) 11 (3.4)
Critically low 0 0
Parity 372 333 .51
0 167 (44.9) 159 (47.7)
1 121 (32.5) 96 (28.8)
>1 84 (22.6) 78 (23.4)
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Table 2 Mean (SD) for sex steroid variables and autism-spectrum quotient (AQ) scores
Males (N = 183) Females (N = 189) p value Cohen’s d
Androgen composite 0.45 (0.27) 0.39 (0.16) .003 0.27
Estrogen composite 98.66 (46.20) 98.84 (45.19) .998 0.004
Androgen to estrogen ratio 0.0052 (0.0027) 0.0046 (0.0026) .02 0.23
AQ
Total 104.49 (10.56) 102.10 (12.26) .05 0.21
Social skills 24.69 (5.58) 23.66 (5.86) .08 0.18
Details/patterns 20.15 (4.64) 18.71 (4.34) .002 0.32
Communication/mindreading 15.02 (2.88) 15.43 (3.50) .21 0.13
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Chi-square analyses revealed a sex difference in the pro-
portion of individuals with high scores for one AQ sub-
scale only. Males (13 %) were significantly more likely
than females (5.3 %) to have a high score (i.e., fall in the
upper decile) on the details/patterns subscale, χ2 = 6.85,
df = 1, p < .01. No other sex differences were observed.
Quartile cutoffs for androgen, estrogen, and A to E ratio
composite values for males and females are shown in
Table 4. Upper decile cutoffs for the subscales of the AQ
were ≥118 (total score), ≥32 (social skills), ≥26 (details/
patterns), and ≥18 (communication/mindreading). Chi-
square analyses revealed that the proportion of high
scores on the details/patterns subscale of the AQ did not
significantly vary as a function of androgen (χ2 = 2.62,
df = 3, p = .45), estrogen (χ2 = .49, df = 3, p = .92), or ratio
(χ2 = 3.20, df = 3, p = .36) quartiles in males. Similarly, in
females, the proportion of high scores did not vary as a
function of estrogen (χ2 = 1.93, df = 3, p = .59) or ratio
(χ2 = 2.14, df = 3, p = .54) quartiles. However, the AQ de-
tails/patterns scores did vary significantly as a function
of androgen quartiles (χ2 = 8.52, df = 3, p < .05, ϕ = 0.21)
where females who fell in quartile 2 (the second lowest
quartile) in androgen composite values were more likely
(36.1 %) than the females in any other quartile to have a
high score on the details/patterns AQ subscale.
As a follow-up to the chi-square analysis for females, a
binary logistic regression analysis was carried out to as-
certain the effect of androgen quartile on the likelihood





1. Total 0.07 (.33) 0.11 (.13)
2. Social skills 0.01 (.90) −0.02 (.76)
3. Patterns/details 0.01 (.87) −0.01 (.92)
4. Communication/mindreading 0.06 (.46) 0.04 (.56)logistic regression model was statistically significant,
χ2(5) = 13.90, p < .05. The model explained 11.5 %
(Nagelkerke R2) of the variance in details/patterns sub-
scale scores and correctly classified 78.1 % of cases.
Females whose androgen levels fell into quartile 2 were
0.34 times more likely to have a high score in the de-
tails/patterns subscale after controlling for covariates.
Clinical ASD
Five children had received a diagnosis of ASD. One male
and one female had been diagnosed with autistic disorder
and three males had been diagnosed with Asperger’s dis-
order. Table 5 presents sex-specific Z scores for the andro-
gen, estrogen, and A to E values of the individuals with
ASD. All but one of the Z scores indicated that sex steroid
values were within one standard deviation of the sex-
specific means. The only exception was a male diagnosed
with Asperger’s disorder whose estrogen composite value
was slightly more than one standard deviation below the
mean (E = 43.12 nM/L, Z = −1.13).
Sample attrition
Previous analyses suggest those who completed the AQ
may be biased in terms of socioeconomic factors com-
pared to those who did not. As a result, final post hoc
analyses examined whether total AQ scores varied ac-
cording to these factors. Independent sample t tests were
conducted and it was found that AQ scores were signifi-
cantly higher, t(360) = 2.15, p < .05, for those participants
whose mother was living below the poverty line durings and scores on the autism-spectrum quotient (AQ) for males
Estrogen composite A to E ratio
Males Females Males Females
0.11 (.13) 0.08 (.30) −0.02 (.83) 0.03 (.71)
0.06 (.41) −0.05 (.52) −0.01 (.94) 0.05 (.49)
0.01 (.91) 0.07 (.31) 0.03 (.69) −0.03 (.69)
−0.01 (.92) 0.06 (.41) 0.02 (.81) −0.01 (.94)
Table 4 Sex steroid quartile cutoffs for males and females
Androgen composite Estrogen composite A to E ratio
Males Females Males Females Males Females
Lower quartile <0.33 <0.29 <64.15 <65.53 <0.0033 <0.0029
Quartile 2 0.33–0.41 0.29–0.37 64.16–90.14 65.53–90.94 0.0033–0.0044 0.0029–0.0040
Quartile 3 0.42–0.51 0.37–0.46 90.15–127.42 90.95–123.92 0.0045–0.0066 0.0041–0.0053
Upper quartile >0.51 >0.46 >127.42 >123.92 >0.0066 >0.0053
Jamnadass et al. Journal of Neurodevelopmental Disorders  (2015) 7:17 Page 8 of 12pregnancy (M = 105.19, SD = 11.38) compared to those
whose mother was not (M = 102.39, SD = 11.63). Simi-
larly, total AQ scores were significantly higher, t(360) =
1.93, p < .05, for the children of mothers who did not
complete secondary education (M = 104.32, SD = 10.53)
compared to the children of mothers who did complete
secondary education (M = 101.96, SD = 12.56). Analyses
of variance showed that AQ scores did not differ sig-
nificantly as a function of maternal age at conception,
F(4, 359) = 0.21, p = .92, maternal smoking during preg-
nancy F(2, 361) = 0.95, p = .39, or alcohol consumption
during pregnancy, F(2, 361) = 1.83, p = .16.
Discussion
The current study explored the relationship between
perinatal sex steroids and autistic-like traits in young
adulthood. To assess perinatal steroid exposure, com-
posites of biologically active androgens and estrogens in
umbilical cord blood were calculated, along with their
ratio. This study is therefore unique in both its biological
methodology (composite sex steroid calculation and um-
bilical cord sampling) and the nature of the longitudinal
data collected (sample size and period over which data
were collected).
Males demonstrated significantly higher androgen and
higher A to E composite ratios than females, though
these effects were small. In contrast, estrogen levels did
not differ significantly between sexes. The significant sex
differences in levels of androgens and A to E composite
ratio are consistent with previous studies suggesting that
males have elevated androgen levels perinatally com-
pared to females [37] .
In regard to sex differences on the AQ, males scored
significantly higher than females on the details/patterns
subscale. This contrasts with two previous studies thatTable 5 Cord blood sex steroid raw values and sex-specific Z scores
Sex Androgen composite Estrogen
Raw value (nM/L) Sex-specific Z score Raw value
Asperger 1 Male 0.41 −0.11 43.
Asperger 2 Male 0.33 −0.48 80.
Asperger 3 Male 0.28 −0.68 68.
Autism 1 Male 0.38 −0.26 98.
Autism 2 Female 0.31 −0.48 104.involved Dutch parent and student samples and a Scot-
tish student sample. These studies showed significantly
higher scores for males in the total AQ score and in the
social skills subscale but not in the details/patterns sub-
scale [57, 61]. The contrasting results found here may
reflect cultural differences between samples. It may also
be that the Raine cohort represents a more general
population sample as opposed to the student and parent
samples involved in the two previous studies.
In contrast to our hypotheses, correlational and regres-
sion analyses of continuous variables revealed no signifi-
cant relationships between sex steroid variables and AQ
scores. In other words, composite indices of concentra-
tions of androgens and estrogens that took into account a
wider range of biologically active sex steroids, as well as
their ratio, did not relate to the total AQ score or any of
the three subscales. Interestingly, when the data were ana-
lyzed categorically, inclusion of covariates in the logistic
regression resulted in a small effect being found for fe-
males, whereby those whose levels of androgens were in
the second lowest quartile scored significantly higher than
those who scored in the other quartiles on the details/pat-
terns subscale. This result, however, is likely to be spurious
given (a) the lack of sex differences found in the outcome
measure, (b) the large number of analyses conducted, and
(c) that animal models generally demonstrate linear rela-
tionships between androgens within the normal range and
behavior. Therefore, the overall pattern of results indicate
that the perinatal composites of androgens and estrogens
as well as their ratio are not significantly related to
autistic-like traits at age 19 and 20 in the general popula-
tion. This further supports the null results found by
Whitehouse et al. (2012) where testosterone concentra-
tions were found to not significantly predict AQ scores in
the Raine cohort.for each individual diagnosed with ASD
composite Ratio
(nM/L) Sex-specific Z score Raw value (nM/L) Sex-specific Z score
12 −1.13 0.0096 0.51
94 −0.31 0.0041 −0.26
60 −0.58 0.0041 −0.25
04 0.06 0.0039 −0.29
54 0.16 0.0030 −0.35
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sibly A to E ratio) would predict higher scores on the AQ
and that those individuals with a clinical diagnosis would
have particularly elevated A composites (and perhaps A to
E ratios). In the current cohort, five participants had a
known diagnosis of ASD. Contrary to expectations, those
participants with an ASD diagnosis did not, overall, dis-
play atypical sex steroid values with all but one falling
within one standard deviation of the mean for the wider
sample. Hence, our findings did not support our primary
hypothesis.
There are several possible explanations for the lack of
relationship between cord blood sex steroid measures
and self-reported autistic-like traits on the AQ. First, it
may be that prenatal sex steroids exert organizational ef-
fects predominantly during the theorized sensitive period
that occurs in early gestation (weeks 8–24). Research
conducted by Baron-Cohen and colleagues as part of the
Cambridge Fetal Testosterone Project has so far demon-
strated several relationships between early social markers
and prenatal testosterone levels obtained via amniocen-
tesis [27–30]. However, organizational effects may occur
during several periods, and furthermore, these periods
may change depending on the area of development in
which the effects are exerted.
Perhaps the sex steroid levels and interactions that
affect aspects of brain development leading to certain
autistic-like traits (e.g., those such as early social behav-
iors) occur early in gestation whereas sex steroids may
influence other neurodevelopmental characteristics (e.g.,
language development) later in gestation. For example,
previous studies have found relationships between peri-
natal testosterone in cord blood and delay in early lan-
guage development in boys [40, 43]. There is neural
evidence to support the development of brain regions in
the third trimester of pregnancy that are central to lan-
guage. During this period, the appearance and growth of
the gyri associated with the posterior and frontal areas,
including perisylvian structures, occurs [62, 63]. These
structures, including the planum temporal, pars triangu-
laris, and the inferior frontal gyrus, are suggested to relate
to language function [64, 65]. Furthermore, postmortem
[66–68] and neuroimaging [69, 70] studies have found
atypical perisylvian structures among children with devel-
opmental language difficulties. Therefore, the neurodeve-
lopmental influence of steroids in the perinatal period
may be informative for language development.
Future investigation could further delineate the pe-
riods of gestation in which sex steroids may play a part
in different aspects of brain development and determine
how we might go about measuring the factors that con-
tribute to this development in a non-intrusive and safe
manner in order to be able to relate these factors to be-
havior later in life.Another potential explanation for these results is that
the extent to which sex steroids are biologically active is
not solely determined by potency and amount. The dis-
tribution and functionality of androgen receptors present
in the fetus may also be important as receptors are re-
sponsible for the binding and translocation of androgens
to the nucleus of cells. Furthermore, the functionality of
these receptors is determined by the androgen receptor
gene which affects the sensitivity of the fetus to androgens
[71]. Studies have found that defects in this gene can re-
sult in complete or partial androgen insensitivity whereby
complete insensitivity results in genotypic males present-
ing as phenotypic females [72, 73]. The cysteine, adenine,
and guanine (CAG) repeat sequence in the androgen re-
ceptor (AR) gene, located at Xq11-12, has been known to
affect serum testosterone levels. More repeats have been
shown to be related to diminished androgen sensitivity
and result in a negative feedback loop that increases an-
drogen production [74]. Studies have demonstrated that
AR-CAGn and serum testosterone levels are positively
correlated in males [75] and inversely associated in fe-
males [76]. Similarly, estrogen uptake relies on the disper-
sion of estrogen-specific receptors. In addition, other sex
steroids such as progesterone and xenoestrogens may
have possible prenatal influences on the developing brain
[77, 78]. Examining sex steroid receptors, their genetic
counterparts, and other possible influencing sex steroids
is another important direction for research in understand-
ing the complexities of prenatal brain development.
Those individuals whose mother was living below the
poverty line as well as children of mothers who did not
complete secondary education had significantly higher
AQ scores. This is consistent with a recent population-
based study in Sweden where low socioeconomic status
was found to be a risk factor for ASD [79]. It may be
that socioeconomic factors are a risk factor for genetic
and or environmental vulnerabilities related to the broad
autism phenotype. It is important to note that the direc-
tion of causation is unknown, and it may be that parents
with autistic-like traits are less likely to complete sec-
ondary education and more likely to live below the pov-
erty line. These parents may have children who are
more likely to have autistic-like traits.
When examining sample attrition characteristics, it
was found that the mothers of the individuals who did
not complete the AQ were socioeconomically disadvan-
taged and were more likely to be younger, less educated
to a secondary level, have an income below the poverty
line, smoke cigarettes, and drink alcohol while pregnant,
relative to the mothers of those who did complete the
AQ. However, sex steroid levels did not differ signifi-
cantly between males who did and did not complete the
AQ. In females, those who completed the AQ did have
significantly lower A to E ratios compared to the women
Jamnadass et al. Journal of Neurodevelopmental Disorders  (2015) 7:17 Page 10 of 12who did not complete the questionnaire, but this effect
was only small. These results suggest socioeconomic sta-
tus in the current study may have influenced drop out
such that those with lower income were more likely to
drop out before completing the AQ.
Conclusions
In summary, the current study provides no evidence to
suggest that perinatal androgens, estrogens, or the A to
E ratio sampled via cord blood predicts autistic-like
traits in young adulthood. However, it does confirm ex-
pectations that higher androgen composite values and
higher A to E ratios in males are present perinatally. It
may be that different organizational effects occur early
in gestation to those of late gestation, and that these are
not evident in the circulating steroid profile at delivery.
It is important to note that the nature of sex steroid recep-
tors and genetic influences may play a part in brain devel-
opment and hence the development of autistic-like traits.
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